Drug Regulation and Pricing--Can Regulators Influence Affordability?

N Engl J Med. 2016 May 12;374(19):1807-9. doi: 10.1056/NEJMp1601294.

Authors

Hans-Georg Eichler¹, Hugo Hurts¹, Karl Broich¹, Guido Rasi¹

Affiliation

¹ From the European Medicines Agency, London (H.-G.E., G.R.); European Medicines Agency Management Board, London (H.H., K.B.); Medical University of Vienna, Vienna (H.-G.E.); College ter Beoordeling van Geneesmiddelen, Utrecht, the Netherlands (H.H.); Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (K.B.); and the University of Rome Tor Vergata, Rome (G.R.).

PMID: 27168431
DOI: 10.1056/NEJMp1601294

No abstract available

MeSH terms

Biomedical Research / economics*
Drug Approval / organization & administration
Drug Costs*
Drug Discovery / economics
Drug Industry / economics*
Drug and Narcotic Control*
Drugs, Generic / economics
Economic Competition
Europe
Government Regulation*
Pharmaceutical Preparations / standards

Substances

Drugs, Generic
Pharmaceutical Preparations